Search Results 2101-2110 of 14732 for anti-TNF drugs

  1. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

    This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...

  2. Butalbital, Acetaminophen, Caffeine, And Codeine (Oral Route) Before Using - Mayo Clinic

    An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

  3. Norepinephrine (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Ketotifen (Oral Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Allergies - Doctors and departments - Mayo Clinic

    Departments that treat this condition · Allergic Diseases · Allergic Rhinitis Specialty Group · Food Allergy Specialty Group · Medication Allergy Specialty Group ...

  6. Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin - Mayo Clinic

    Known human immunodeficiency virus (HIV) infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months and CD4 T cell ...

  7. Sunscreen Agent (Topical Application Route) Before Using - Mayo Clinic

    Your doctor may also advise you to take vitamin D supplements. Check with your doctor about this. Drug Interactions. Although certain medicines should not be ...

  8. A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab - Mayo Clinic

    The purpose of this study is to compare the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) in ...

  9. Reversing NOACs presents challenges - Mayo Clinic

    Unlike warfarin, novel oral anticoagulants (NOACs) have no universal antidote. Options for reversing NOACs other than dabigatran range from holding the drug ...

  10. A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/​A011-16) - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of sotatercept versus placebo in adults with Cpc-PH due to HFpEF. Effectiveness is ...